Provided by Tiger Fintech (Singapore) Pte. Ltd.

Edwards Lifesciences

69.29
+1.341.97%
Post-market: 69.290.00000.00%17:31 EDT
Volume:3.59M
Turnover:248.16M
Market Cap:40.74B
PE:9.94
High:69.66
Open:68.43
Low:67.78
Close:67.95
Loading ...

Edwards Lifesciences Director Makes a Significant Stock Sale!

TIPRANKS
·
15 Feb

Director Cashes In on Edwards Lifesciences Stock in Major Sale

TIPRANKS
·
14 Feb

Edwards Lifesciences Is Maintained at Overweight by Barclays

Dow Jones
·
13 Feb

Edwards Lifesciences: Promising Growth with Strong Performance in TMTT and TAVR Segments Justifies Buy Rating

TIPRANKS
·
13 Feb

Edwards Lifesciences price target raised to $71 from $66 at Canaccord

TIPRANKS
·
13 Feb

Edwards Lifesciences Corp : Canaccord Genuity Raises Target Price to $71 From $68

THOMSON REUTERS
·
13 Feb

Edwards Lifesciences: Strong Q4 Performance Overshadowed by Unchanged 2025 Outlook and Capacity Constraints

TIPRANKS
·
13 Feb

Edwards Lifesciences’ Earnings Call Highlights Strong Growth

TIPRANKS
·
13 Feb

Evercore ISI Reaffirms Their Hold Rating on Edwards Lifesciences (EW)

TIPRANKS
·
13 Feb

Heart Devices-Focused Edwards Lifesciences Confident in 2025 Outlook, Analyst Sees Long-Term Strength

Benzinga
·
13 Feb

Edwards Lifesciences Price Target Maintained With a $85.00/Share by RBC Capital

Dow Jones
·
13 Feb

Q4 2024 Edwards Lifesciences Corp Earnings Call

Thomson Reuters StreetEvents
·
12 Feb

Edwards Lifesciences Is Maintained at Neutral by Piper Sandler

Dow Jones
·
12 Feb

Stock Track | Edwards Lifesciences Soars 5.4% on Strong Q4 Revenue Growth and Positive Outlook

Stock Track
·
12 Feb

BUZZ-Edward Lifesciences rises as demand for heart device drives Q4 profit beat

Reuters
·
12 Feb

Edwards Lifesciences Is Maintained at In-Line by Evercore ISI Group

Dow Jones
·
12 Feb